United Therapeutics Corporation finishes enrolling participants in ADVANCE OUTCOMES study
United Therapeutics is a company dedicated to advancing medical science and improving the lives of patients with serious illnesses. Founded by visionaries in the healthcare industry, United Therapeutics has grown to have a significant presence in various locations worldwide.
The company has a strong commitment to corporate responsibility, operating as a Public Benefit Corporation and engaging in initiatives that benefit the community and the environment. Their corporate giving programs reflect this commitment, with a focus on improving access to healthcare and supporting underserved populations.
United Therapeutics is at the forefront of research and medicine, developing innovative therapies to treat a range of conditions. Their portfolio of medicines includes Remodulin, Tyvaso, Orenitram, Adcirca, and Unituxin, which are used to treat serious diseases such as pulmonary arterial hypertension and neuroblastoma.
In addition to their existing medications, United Therapeutics is actively involved in research and development, exploring new therapeutic areas and conducting clinical trials to bring new treatments to patients in need. Their pipeline of promising therapies reflects their dedication to advancing medical science and improving patient outcomes.
For medical professionals, United Therapeutics offers a range of resources through their Science and Medical Affairs department. This team is dedicated to providing information and support to healthcare professionals, ensuring that they have access to the latest research and scientific knowledge to better serve their patients.
United Therapeutics’ commitment to innovation and patient care is evident in everything they do. By focusing on developing new therapies, supporting medical professionals, and giving back to the community, they are making a significant impact on the lives of patients with serious illnesses. With a strong leadership team and a history of groundbreaking achievements, United Therapeutics is poised to continue making a difference in the field of healthcare for years to come.